68 related articles for article (PubMed ID: 26980026)
1. HB-EGF Plasmatic Level Contributes to the Development of Early Risk Prediction Nomogram for Severe COVID-19 Cases.
Moatar AI; Chis AR; Nitusca D; Oancea C; Marian C; Sirbu IO
Biomedicines; 2024 Feb; 12(2):. PubMed ID: 38397975
[TBL] [Abstract][Full Text] [Related]
2. Malignant mixed mullerian tumors: a SEER database review of rurality and treatment modalities on disease outcome.
Zadeh N; Bhatt A; Sripiparu V; Pasli M; Edwards G; Larkins MC; Peach MS
Front Oncol; 2024; 14():1296496. PubMed ID: 38390260
[TBL] [Abstract][Full Text] [Related]
3. Brain Metastasis in a Young Patient with Uterine Carcinosarcoma.
Katiyar V; Araujo T; Farooq MZ; Vohra I; Gupta S
Cureus; 2019 Jun; 11(6):e5010. PubMed ID: 31497440
[TBL] [Abstract][Full Text] [Related]
4. [Clinical utility of serous tumoural markers].
Martín Suárez A; Alonso Díaz L; Ordiz Alvarez I; Vázquez J; Vizoso Piñeiro F
Aten Primaria; 2003; 32(4):227-39. PubMed ID: 12975087
[No Abstract] [Full Text] [Related]
5. Forkhead Box q1 promotes invasion and metastasis in colorectal cancer by activating the epidermal growth factor receptor pathway.
Zhang JJ; Cao CX; Wan LL; Zhang W; Liu ZJ; Wang JL; Guo Q; Tang H
World J Gastroenterol; 2022 May; 28(17):1781-1797. PubMed ID: 35633908
[TBL] [Abstract][Full Text] [Related]
6. Malignant mixed Mullerian tumor of the ovary with two cases and review of the literature.
Duman BB; Kara IO; Günaldi M; Ercolak V
Arch Gynecol Obstet; 2011 Jun; 283(6):1363-8. PubMed ID: 21298439
[TBL] [Abstract][Full Text] [Related]
7. Malignant mullerian mixed tumors of the uterine cervix: a report of nine cases of a neoplasm with morphology often different from its counterpart in the corpus.
Clement PB; Zubovits JT; Young RH; Scully RE
Int J Gynecol Pathol; 1998 Jul; 17(3):211-22. PubMed ID: 9656116
[TBL] [Abstract][Full Text] [Related]
8. Serous carcinomatous component championed by heparin-binding EGF-like growth factor (HB-EGF) predisposing to metastasis and recurrence in stage I uterine malignant mixed mullerian tumor.
Zhang L; Shimizu D; Killeen JL; Honda SA; Lu D; Stanoyevitch A; Lin F; Wang B; Monuki ES; Carbone M
Hum Pathol; 2016 Jul; 53():159-67. PubMed ID: 26980026
[TBL] [Abstract][Full Text] [Related]
9. A clinical and biological comparison between malignant mixed müllerian tumors and grade 3 endometrioid endometrial carcinomas.
Bland AE; Stone R; Heuser C; Shu J; Jazaeri A; Shutter J; Atkins K; Rice L
Int J Gynecol Cancer; 2009 Feb; 19(2):261-5. PubMed ID: 19396006
[TBL] [Abstract][Full Text] [Related]
10. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
[TBL] [Abstract][Full Text] [Related]
11. A clinical and pathologic comparison between stage-matched endometrial intraepithelial carcinoma and uterine serous carcinoma: is there a difference?
Hou JY; McAndrew TC; Goldberg GL; Whitney K; Shahabi S
Reprod Sci; 2014 Apr; 21(4):532-7. PubMed ID: 24023030
[TBL] [Abstract][Full Text] [Related]
12. Malignant mixed müllerian tumor of the ovary: report of a case and review of the literature.
Shy SW; Lee WH; Lee MS; Lee MC
Zhonghua Yi Xue Za Zhi (Taipei); 1993 Jun; 51(6):468-73. PubMed ID: 8281496
[TBL] [Abstract][Full Text] [Related]
13. Malignant mixed Müllerian tumors of the uterus: a clinicopathologic, DNA flow cytometric, p53, and mdm-2 analysis of 44 cases.
Blom R; Guerrieri C; Stâl O; Malmström H; Sullivan S; Simonsen E
Gynecol Oncol; 1998 Jan; 68(1):18-24. PubMed ID: 9454654
[TBL] [Abstract][Full Text] [Related]
14. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
